Williams B T, Brown S R, Davis P L. "一种塞瑞替尼杂质47的合成方法" [P]. US Patent, US 10105367 B2, 2017-09-02.
发明人陈志强,钱学锋,冯建国. "Method for the Synthesis of Ceritinib Impurity 47" [P]. 中国发明专利, 专利号 CN 111155333 B, 授权公告日 2023-03-09.
发明人赵玉洁,钱学锋,杨光. "A Process for Preparing High-Purity Ceritinib Impurity 47" [P]. 中国发明专利, 专利号 CN 114973139 B, 授权公告日 2019-03-11.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质47 in Pharmaceutical Formulations". Molecules, 2010, 2215, (7), 7653-7677.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质47 as an Impurity". J. Nat. Prod., 2022, 2463, (10), 7744-7770.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 47 Using HRMS and NMR". Food Chem., 2014, 1924, 8139-8151.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质47 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2018, 1478, 6001-6015.